Australian Ethical Australian Shr WS is an Managed Funds investment product that is benchmarked against ASX Index MidCap 50 Index and sits inside the Domestic Equity - Mid/Small Blend Index. Think of a benchmark as a standard where investment performance can be measured. Typically, market indices like the ASX200 and market-segment stock indexes are used for this purpose. The Australian Ethical Australian Shr WS has Assets Under Management of 633.93 M with a management fee of 1.1%, a performance fee of 0.00% and a buy/sell spread fee of 0.4%.
The recent investment performance of the investment product shows that the Australian Ethical Australian Shr WS has returned 4.2% in the last month. The previous three years have returned 2.7% annualised and 13.34% each year since inception, which is when the Australian Ethical Australian Shr WS first started.
There are many ways that the risk of an investment product can be measured, and each measurement provides a different insight into the risk present. They can be used on their own or together to perform a risk assessment before investing, but when comparing investments, it is common to compare like for like risk measurements to determine which investment holds the most risk. Since Australian Ethical Australian Shr WS first started, the Sharpe ratio is NA with an annualised volatility of 13.34%. The maximum drawdown of the investment product in the last 12 months is -6.28% and -27.74% since inception. The maximum drawdown is defined as the high-to-low decline of an investment during a particular time period.
Relative performance is what an asset achieves over a period of time compared to similar investments or its peers. Relative return is a measure of the asset's performance compared to the return to the other investment. The Australian Ethical Australian Shr WS has a 12-month excess return when compared to the Domestic Equity - Mid/Small Blend Index of 1.22% and 3.07% since inception.
Alpha is an investing term used to measure an investment's outperformance relative to a market benchmark or peer investment. Alpha describes the excess return generated when compared to peer investment. Australian Ethical Australian Shr WS has produced Alpha over the Domestic Equity - Mid/Small Blend Index of NA% in the last 12 months and NA% since inception.
For a full list of investment products in the Domestic Equity - Mid/Small Blend Index category, you can click here for the Peer Investment Report.
Australian Ethical Australian Shr WS has a correlation coefficient of 0.94 and a beta of 1.03 when compared to the Domestic Equity - Mid/Small Blend Index. Correlation measures how similarly two investments move in relation to one another. This establishes a 'correlation coefficient', which has a value between -1.0 and +1.0. A 100% correlation between two investments means that the correlation coefficient is +1. Beta in investments measures how much the price moves relative to the broader market over a period of time. If the investment moves more than the broader market, it has a beta above 1.0. If it moves less than the broader market, then the beta is less than 1.0. Investments with a high beta tend to carry more risk but have the potential to deliver higher returns.
For a full quantitative report on Australian Ethical Australian Shr WS and its peer investments, you can click here for the Peer Investment Report.
For a full quantitative report on Australian Ethical Australian Shr WS compared to the ASX Index MidCap 50 Index, you can click here.
To sort and compare the Australian Ethical Australian Shr WS financial metrics, please refer to the table above.
This investment product is in the process of being independently verified by SMSF Mate. Once we have verified the investment product, you will be able to find more information here.
If you or your self managed super fund would like to invest in the Australian Ethical Australian Shr WS please contact Level 8, 130 Pitt Street. Sydney NSW 2000 via phone 1800 021 227 or via email enquiries@australianethical.com.au.
If you would like to get in contact with the Australian Ethical Australian Shr WS manager, please call 1800 021 227.
SMSF Mate does not receive commissions or kickbacks from the Australian Ethical Australian Shr WS. All data and commentary for this fund is provided free of charge for our readers general information.
The Australian Shares Fund fell -18.2% (-18.0% Wholesale) underperforming its benchmark which fell -12.2% over the June Quarter. The primary reason for the underperformance is the divergence in performance of small companies compared to large cap Australian companies noting the Fund has greater than 50% of its investment outside the ASX100.
This underperformance is specifically attributed to the Funds significant overweight allocation into the information technology sector, the weakest performing sector, with healthcare also a laggard. The technology sell-off has been led out of the US, with microcap and small-cap companies in their earlier stage of commercial development particularly hard hit. We continue to believe superior growth attributes are the primary reason for investing into small and microcap companies, irrespective of interest rates and consequently have been adding to some of our underperforming names. We believe there will be merger and acquisition activity if share prices remain weak.
The number one issue global investors are grappling with is the emergence of supply chain driven inflation. This inflation is driving future interest rate expectations up. Soft and hard commodity owners are beneficiaries in an inflationary environment as commodity prices tend to keep pace with inflation while high growth companies, particularly those in the earlier stage of commercialisation, are getting penalised by investors through the discounting of their earnings by a higher rate and through the fact significant earnings are still several years off. We attribute our underperformance to global inflationary concerns. The Australian Shares Fund underperformed its benchmark over the quarter: -1.1% vs +2.2% (Wholesale -1.0 vs +2.2%). The underperformance is attributed to small companies underperforming large companies in this quarter and the Funds significant underweight in materials, with mining companies performing very strongly.
Global markets posted another strong quarter with the MSCI World Index appreciating 7.7%. This was driven by the US where the S&P 500 rose 8.6%. Australia kept pace, with the ASX 200 up 8.3% driven by cyclical sectors Financials and Materials. Performance in equity markets was driven by improved economic activity, the roll out of the vaccination program and strong monetary and fiscal support. This improved economic activity was reflected in a rising Purchasing Managers’ Index. Unemployment rates are falling faster than anticipated, and YoY Inflation rates have continued to rise – prompting investors to pay close attention to how Central Banks will react.
The Australian Shares Fund (retail) returned 9.1% (Wholesale class: 9.3%), outperforming its benchmark index over the quarter by 0.6% (Wholesale class: 0.8%) with technology names leading this outperformance. The strong technology companies include SaaS company Bigtincan, telematics company Eroad, wealth management software company Bravura Solutions, PDF and e-signature company Nitro Software. The strongest individual stock contributor was real-estate company Mirvac which appreciated strongly after its property portfolio was not significantly impacted by Covid-19. Another individual strong stock performer was neurologically focussed contract research organisation Cogstate after an Alzheimer’s drug was approved by the FDA. Hearing company Cochlear business continues to rebound while renewable energy company Contact Energy recovered some of its previous losses on news it was expanding its geothermal generation
The opportunity to invest in a diversified share portfolio of companies predominately listed on the ASX and selected on the basis of their social, environmental and financial credentials. The Fund utilises an active stock-picking management style with stocks generally selected for growth rather than income, with a bias towards smaller capitalisation stocks listed on the ASX. All stocks are chosen on the basis of relative value where we deem the risks are being adequately priced.
For the quarter, the Fund achieved an absolute return of 19.5% (19.8% Wholesale Fund) against the fund’s benchmark, the S&P/ASX 300 Index, which advanced 13.8%. The Australian Shares Fund 12-month performance was +19.9% (21% Wholesale Fund) against 1.7% gain for the benchmark. We were very pleased with the relative outperformance of the fund over recent periods.
Over the quarter Financials, Healthcare, Materials and Utilities sectoral exposures drove the outperformance with both small and large capitalised companies contributing to this outperformance.The US general election win by Joe Biden is seen as a positive for climate change, while the growth of ESG funds around the world saw the market chasing many renewable and adjacent assets. The renewable energy generators and retailers out of New Zealand including Meridian Energy (+51.7%), Contact Energy (+35.6%) and Mercury Energy (29.6%) were among the leading contributors while lithium producer Pilbara Minerals (+187.4%) was among our top 10 performers.
The December quarter saw banks make strong recoveries with regional bank Bendigo & Adelaide Bank the strongest single contributor to performance, appreciating 54%, with Bank of Queensland not far behind +35.1%. We were also pleased to see mortgage insurer Genworth Australia bounce back 52.7% with all banking related stocks benefiting from an improved outlook for residential property.The Fund continues to be actively managed.
For the quarter, the Fund pleasingly achieved an absolute return of 9.1% (9.4% Wholesale Fund) against the fund’s benchmark, the S&P/ASX 300 Index, which declined 0.1%. The Australian Shares Fund’s 12-month performance was 1.5% (2.4% wholesale) against negative 10% for the benchmark.
The Australian market started the quarter strongly, with August particularly strong (ASX 200 up 2.2%) boosted by some better-than-expected earnings in the reporting season, solid economic data and renewed hopes for a vaccine. However, September saw the five-month rally end with the ASX 200 falling 4% as investors became nervous about fears of a second global COVID-19 wave, poor sentiment regarding the US Presidential election and growth concerns.
Locally, the effects of the lockdown in Victoria became more apparent, with a higher level of unemployment and Federal Treasurer Josh Frydenberg warning the Australian economy was set to contract by 6% more than forecast by the end of 2021. The quarterly outperformance is attributed to both the fund being tilted towards small companies (which outperformed large companies) and very strong stock selection in our small-cap names.
The key sector contributors were IT and healthcare with PDF and e-signature software company Nitro Software appreciating +88% while sales enablement software-as-a-service company Bigtincan was up 82%. Other good contributors included educational technology company 3PL, the owner of Mathletics, which appreciated +55% benefiting from a takeover offer
Product Snapshot
Product Overview
Performance Review
Peer Comparison
Product Details